Role of Helicobacter pylori in gastric cancer: Updates

World Journal of Gastrointestinal Oncology

Volumn 8, Issue 2, 2016, Pages 147-158

  Khatoon, Jahanarah ^a   Rai, Ravi Prakash ^a   Prasad, Kashi Nath ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cag pathogenicity island; Gastric cancer; Gastric mucosa; Helicobacter pylori; Type IV secretion system

Indexed keywords

EID: 84986605844     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/WJGO.V8.I2.147     Document Type: Article

References (112)

1. 1 Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315 [PMID: 6145023 DOI: 10.1016/S0140-6736(84)91816-6]
2. 2 Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010; 23: 713-739 [PMID: 20930071 DOI: 10.1128/CMR.00011-10]
3. 3 Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJM oa001999]
4. 4 Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 559-578 [PMID: 11030073 DOI: 10.1016/S0889-8553(05)70130-8]
5. 5 Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54: 615-640 [PMID: 11018139 DOI: 10.1146/annurev.micro.54.1.615]
6. 6 Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996; 93: 2239-2244 [PMID: 8637856 DOI: 10.1073/pnas.93.6.2239]
7. 7 Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-1540 [PMID: 15985559 DOI: 10.1136/gut.2005.072009]
8. 8 Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194 [PMID: 14722144 DOI: 10.1001/ jama.291.2.187]
9. 9 Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T, Sugiyama A, Mizoshita T, Kaminishi M, Tatematsu M. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002; 93: 1083-1089 [PMID: 12417037 DOI: 10.1111/ j.1349-7006.2002.tb01209.x]
10. 10 Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008; 88: 328-336 [PMID: 18180700 DOI: 10.1038/labinvest.3700719]
11. 11 Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-773 [PMID: 11285290 DOI: 10.1172/JCI12672]
12. 12 Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740 [PMID: 1458460]
13. 13 Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
14. 14 Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 2014; 50: 1330-1344 [PMID: 24650579]
15. 15 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269]
16. 16 Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J 2014; 55: 621-628 [PMID: 25630323 DOI: 10.11622/smedj.2014174]
17. 17 Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156 [PMID: 11668491]
18. 18 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362 [PMID: 16489633]
19. 19 McColl KE. Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol 2006; 20: 687-696 [PMID: 16997153 DOI: 10.1016/ j.bpg.2006.03.005]
20. 20 Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20: 633-649 [PMID: 16997150 DOI: 10.1016/ j.bpg.2006.04.008]
21. 21 Klein PD, Graham DY, Gaillour A, Opekun AR, Smith EO. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet 1991; 337: 1503-1506 [PMID: 1675369 DOI: 10.1016/0140-6736 (91)93196-G]
22. 22 Hopkins RJ, Vial PA, Ferreccio C, Ovalle J, Prado P, Sotomayor V, Russell RG, Wasserman SS, Morris JG. Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis 1993; 168: 222-226 [PMID: 8515115 DOI: 10.1093/infdis/168.1.222]
23. 23 Nurgalieva ZZ, Malaty HM, Graham DY, Almuchambetova R, Machmudova A, Kapsultanova D, Osato MS, Hollinger FB, Zhangabylov A. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg 2002; 67: 201-206 [PMID: 12389948]
24. 24 Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 205-214 [PMID: 17382273 DOI: 10.1016/j.bpg.2006.10.005]
25. 25 Eaton KA, Morgan DR, Krakowka S. Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 1989; 57: 1119-1125 [PMID: 2925243]
26. 26 Scott D, Weeks D, Melchers K, Sachs G. The life and death of Helicobacter pylori. Gut 1998; 43 Suppl 1: S56-S60 [PMID: 9764042 DOI: 10.1136/gut.43.2008.S56]
27. 27 Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528 [PMID: 7791437 DOI: 10.1016/S0140-6736(95)91084-0]
28. 28 Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-177 [PMID: 3871738 DOI: 10.1002/ijc.2910350206]
29. 29 Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791 [PMID: 11606491 DOI: 10.1053/gast.2001.27999]
30. 30 Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259 [PMID: 9766647]
31. 31 Rieder G, Merchant JL, Haas R. Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce pre-cancerous conditions in Mongolian gerbils. Gastroenterology 2005; 128: 1229-1242 [PMID: 15887107 DOI: 10.1053/j.gastro.2005.02.064]
32. 32 Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648 [PMID: 9721161 DOI: 10.1016/S0016-5085(98)70143-X]
33. 33 Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321-333 [PMID: 14755326 DOI: 10.1172/JCI20925]
34. 34 Harford WV, Barnett C, Lee E, Perez-Perez G, Blaser MJ, Peterson WL. Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. Gut 2000; 47: 467-472 [PMID: 10986205 DOI: 10.1136/gut.47.4.467]
35. 35 El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, Williams C, Fullarton G, McColl KE. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118: 22-30 [PMID: 10611150]
36. 36 El-Omar EM. Role of host genes in sporadic gastric cancer. Best Pract Res Clin Gastroenterol 2006; 20: 675-686 [PMID: 16997152 DOI: 10.1016/j.bpg.2006.04.006]
37. 37 Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 2979-2990 [PMID: 16718776]
38. 38 El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201 [PMID: 12730860 DOI: 10.1016/S0016-5085(03)00157-4]
39. 39 Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 2004; 189: 1914-1920 [PMID: 15122529 DOI: 10.1086/386289]
40. 40 Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000; 287: 482-485 [PMID: 10642549 DOI: 10.1126/science.287.5452.482]
41. 41 Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687 [PMID: 12441323 DOI: 10.1093/jnci/94.22.1680]
42. 42 Kirschner DE, Blaser MJ. The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol 1995; 176: 281-290 [PMID: 7475116 DOI: 10.1006/jtbi.1995.0198]
43. 43 Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37 [PMID: 11902583 DOI: 10.1038/nrc703]
44. 44 Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1: 11-21 [PMID: 11900248 DOI: 10.1038/35094017]
45. 45 Miyamoto T, Ogino N, Yamamoto S, Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 1976; 251: 2629-2636 [PMID: 816795]
46. 46 Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997; 100: 1325-1329 [PMID: 9294096 DOI: 10.1172/JCI119651]
47. 47 Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, Acquaviva AM, Del Vecchio Blanco C, Bruni CB, Zarrilli R. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998; 273: 28560-28563 [PMID: 9786845 DOI: 10.1074/jbc.273.44.28560]
48. 48 Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999; 116: 1319-1329 [PMID: 10348815 DOI: 10.1016/S0016-5085(99)70496-8]
49. 49 Jüttner S, Cramer T, Wessler S, Walduck A, Gao F, Schmitz F, Wunder C, Weber M, Fischer SM, Schmidt WE, Wiedenmann B, Meyer TF, Naumann M, Höcker M. Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors. Cell Microbiol 2003; 5: 821-834 [PMID: 14531897 DOI: 10.1046/j.1462-5822.2003.00324.x]
50. 50 Akre K, Ekström AM, Signorello LB, Hansson LE, Nyren O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer 2001; 84: 965-968 [PMID: 11286478 DOI: 10.1054/bjoc.2001.1702]
51. 51 Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, Oshima M. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 2008; 27: 1671-1681 [PMID: 18511911 DOI: 10.1038/emboj.2008.105]
52. 52 Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-1008 [PMID: 18192401 DOI: 10.1073/pnas.0711183105]
53. 53 Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37-53 [PMID: 9593295 DOI: 10.1046/ j.1365-2958.1998.00770.x]
54. 54 Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-14653 [PMID: 8962108 DOI: 10.1073/pnas.93.25.14648]
55. 55 Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med 2000; 191: 587-592 [PMID: 10684850 DOI: 10.1084/jem.191.4.587]
56. 56 Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-610 [PMID: 2307514]
57. 57 Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332-335 [PMID: 1677696 DOI: 10.1016/0140-673 6(91)90477-7]
58. 58 Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999; 397: 176-180 [PMID: 9923682 DOI: 10.1038/16495]
59. 59 Simän JH, Forsgren A, Berglund G, Floren CH. Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 2001; 36: 208-213 [PMID: 11252415 DOI: 10.1080/003655201750065988]
60. 60 Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-565 [PMID: 7834625]
61. 61 Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339-1343 [PMID: 8244098 DOI: 10.1136/gut.34.10.1339]
62. 62 Queiroz DM, Mendes EN, Rocha GA, Oliveira AM, Oliveira CA, Magalhães PP, Moura SB, Cabral MM, Nogueira AM. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int J Cancer 1998; 78: 135-139 [PMID: 9754640 DOI: 10.1002/(SICI)1097-0215(19981005)78:2<135::AID-IJC1>3.0.CO;2-#]
63. 63 Vorobjova T, Nilsson I, Kull K, Maaroos HI, Covacci A, Wadström T, Uibo R. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur J Gastroenterol Hepatol 1998; 10: 41-46 [PMID: 9512952 DOI: 10.1097/00042737-199801000-00008]
64. 64 Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301 [PMID: 9135515 DOI: 10.1136/gut.40.3.297]
65. 65 Peek RM, Miller GG, Tham KT, Pérez-Pérez GI, Cover TL, Atherton JC, Dunn GD, Blaser MJ. Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol 1995; 33: 28-32 [PMID: 7699060]
66. 66 Torres J, Pérez-Pérez GI, Leal-Herrera Y, Muñoz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer 1998; 78: 298-300 [PMID: 9766561 DOI: 10.1002/(SICI)1 097-0215(19981029)78:3<298::AID-IJC6>3.0.CO;2-Q]
67. 67 Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, Suzuki T, Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602 [PMID: 10684851 DOI: 10.1084/jem.191.4.593]
68. 68 Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1500 [PMID: 10688800 DOI: 10.1126/science.287.5457.1497]
69. 69 Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-14564 [PMID: 10588744 DOI: 10.1073/ pnas.96.25.14559]
70. 70 Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43: 971-980 [PMID: 11929545 DOI: 10.1046/ j.1365-2958.2002.02781.x]
71. 71 Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268 [PMID: 10655519 DOI: 10.1073/pnas.97.3.1263]
72. 72 Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4: 688-694 [PMID: 15343275 DOI: 10.1038/nrc1433]
73. 73 Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T, Hatakeyama M. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 2005; 280: 23130-23137 [PMID: 15831497 DOI: 10.1074/jbc.M503583200]
74. 74 Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, Rugge M, Plebani M, Atherton JC. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-99 [PMID: 18474244 DOI: 10.1053/j.gastro.2008.03.041]
75. 75 Argent RH, Hale JL, El-Omar EM, Atherton JC. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol 2008; 57: 1062-1067 [PMID: 18719174 DOI: 10.1099/jmm.0.2008/001818-0]
76. 76 Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686 [PMID: 11743164]
77. 77 Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003; 278: 3664-3670 [PMID: 12446738 DOI: 10.1074/jbc. M208155200]
78. 78 Moese S, Selbach M, Kwok T, Brinkmann V, König W, Meyer TF, Backert S. Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect Immun 2004; 72: 3646-3649 [PMID: 15155677 DOI: 10.1128/ IAI.72.6.3646-3649.2004]
79. 79 Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 2006; 26: 261-276 [PMID: 16354697 DOI: 10.1128/ MCB.26.1.261-276.2006]
80. 80 Bourzac KM, Botham CM, Guillemin K. Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. Infect Immun 2007; 75: 1203-1213 [PMID: 17194805 DOI: 10.1128/ IAI.01702-06]
81. 81 Moese S, Selbach M, Brinkmann V, Karlas A, Haimovich B, Backert S, Meyer TF. The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell Microbiol 2007; 9: 1148-1161 [PMID: 17217431 DOI: 10.1111/j.1462-5822.2006.00856.x]
82. 82 Selbach M, Moese S, Backert S, Jungblut PR, Meyer TF. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 2004; 4: 2961-2968 [PMID: 15378755 DOI: 10.1002/pmic.200400915]
83. 83 Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 2003; 22: 515-528 [PMID: 12554652 DOI: 10.1093/emboj/ cdg050]
84. 84 Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434 [PMID: 12775840 DOI: 10.1126/science.1081919]
85. 85 Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 2005; 102: 16339-16344 [PMID: 16258069 DOI: 10.1073/pnas.0502598102]
86. 86 Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O'Brien DP, Romero-Gallo J, Peek RM. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 2005; 102: 10646-10651 [PMID: 16027366 DOI: 10.1073/pnas.0504927102]
87. 87 Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM, Azuma T, Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26: 4617-4626 [PMID: 17237808]
88. 88 Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-333 [PMID: 17507984 DOI: 10.1038/nature05765]
89. 89 Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med 2005; 202: 1235-1247 [PMID: 16275761 DOI: 10.1084/jem.20051027]
90. 90 Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003; 161: 249-255 [PMID: 12719469 DOI: 10.1083/jcb.200208039]
91. 91 Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem 2009; 284: 23024-23036 [PMID: 19553659 DOI: 10.1074/jbc. M109.001008]
92. 92 Murata-Kamiya N, Kikuchi K, Hayashi T, Higashi H, Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010; 7: 399-411 [PMID: 20478541 DOI: 10.1016/j.chom.2010.04.005]
93. 93 Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005; 3: 320-332 [PMID: 15759043 DOI: 10.1038/nrmicro1095]
94. 94 Wroblewski LE, Peek RM. Helicobacter pylori in gastric carcinogenesis: mechanisms. Gastroenterol Clin North Am 2013; 42: 285-298 [PMID: 23639641]
95. 95 Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-1888 [PMID: 11106679 DOI: 10.1093/ jnci/92.23.1881]
96. 96 Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005; 96: 1-6 [PMID: 15649247]
97. 97 Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13: 162-168 [PMID: 12749604 DOI: 10.2188/jea.13.162]
98. 98 Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y, Matsumoto T, Iida M. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119: 196-201 [PMID: 16450397 DOI: 10.1002/ ijc.21822]
99. 99 Beevers DG, Lip GY, Blann AD. Salt intake and Helicobacter pylori infection. J Hypertens 2004; 22: 1475-1477 [PMID: 15257168 DOI: 10.1097/01.hjh.0000133736.77866.77]
100. 100 Gamboa-Dominguez A, Ubbelohde T, Saqui-Salces M, Romano-Mazzoti L, Cervantes M, Dominguez-Fonseca C, de la Luz Estreber M, Ruiz-Palacios GM. Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils. Dig Dis Sci 2007; 52: 1517-1526 [PMID: 17404882 DOI: 10.1007/s10620-006-9524-3]
101. 101 Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, Katsuyama T, Asaka M, Tatematsu M. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer 2006; 119: 1558-1566 [PMID: 16646055 DOI: 10.1002/ijc.21810]
102. 102 Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208: 233-248 [PMID: 16362989 DOI: 10.1002/ path.1868]
103. 103 Gancz H, Jones KR, Merrell DS. Sodium chloride affects Helicobacter pylori growth and gene expression. J Bacteriol 2008; 190: 4100-4105 [PMID: 18375562 DOI: 10.1128/JB.01728-07]
104. 104 Loh JT, Torres VJ, Cover TL. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 2007; 67: 4709-4715 [PMID: 17510398 DOI: 10.1158/0008-5472.CAN-06-4746]
105. 105 Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the ‘antioxidant hypothesis'. Public Health Nutr 2004; 7: 407-422 [PMID: 15153272 DOI: 10.1079/ PHN2003543]
106. 106 Ekström AM, Serafini M, Nyrén O, Hansson LE, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a populationbased case-control study in Sweden. Int J Cancer 2000; 87: 133-140 [PMID: 10861464 DOI: 10.1002/1097-0215(20000701)8 7:1<133::AID-IJC20>3.0.CO;2-E]
107. 107 Epplein M, Nomura AM, Hankin JH, Blaser MJ, Perez-Perez G, Stemmermann GN, Wilkens LR, Kolonel LN. Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Cancer Causes Control 2008; 19: 869-877 [PMID: 18369531 DOI: 10.1007/s10552-008-9149-2]
108. 108 Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, Norat T, Friesen M, Tj⊘nneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Touvier M, Boeing H, Schulz M, Linseisen J, Nagel G, Trichopoulou A, Naska A, Oikonomou E, Krogh V, Panico S, Masala G, Sacerdote C, Tumino R, Peeters PH, Numans ME, Bueno-de-Mesquita HB, Büchner FL, Lund E, Pera G, Sanchez CN, Sánchez MJ, Arriola L, Barricarte A, Quirós JR, Hallmans G, Stenling R, Berglund G, Bingham S, Khaw KT, Key T, Allen N, Carneiro F, Mahlke U, Del Giudice G, Palli D, Kaaks R, Gonzalez CA. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 2006; 27: 2250-2257 [PMID: 16774936 DOI: 10.1093/carcin/bgl096]
109. 109 Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol 2008; 168: 1409-1415 [PMID: 18945691 DOI: 10.1093/aje/kwn276]
110. 110 Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stümer T. Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 2002; 98: 446-449 [PMID: 11920598 DOI: 10.1002/ijc.10201]
111. 111 Fox JG, Beck P, Dangler CA, Whary MT, Wang TC, Shi HN, Nagler-Anderson C. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 2000; 6: 536-542 [PMID: 10802709 DOI: 10.1038/75015]
112. 112 Whary MT, Sundina N, Bravo LE, Correa P, Quinones F, Caro F, Fox JG. Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1464-1469 [PMID: 15941957 DOI: 10.1158/1055-9965. EPI-05-0095]